← All organizations
Highest phase reached
Phase 4
First clinical trial
May 8, 2019Last known activity
Jun 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 11 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (16)
- NCT07176949Lead sponsorN/AJun 1, 2025
- NCT06877494Lead sponsorPhase 2Jul 21, 2024
- NCT06305143Lead sponsorPhase 4Apr 1, 2024
- NCT05939882Study directorN/AApr 1, 2023
- NCT05939882Lead sponsorN/AApr 1, 2023
- NCT05597163Study directorN/ANov 1, 2022
- NCT05597163Lead sponsorN/ANov 1, 2022
- NCT05449015Lead sponsorPhase 4Jul 31, 2022
- NCT05449015Study directorPhase 4Jul 31, 2022
- NCT05203432Overall official - principal investigatorN/AFeb 10, 2022
- NCT05203432Lead sponsorN/AFeb 10, 2022
- NCT05448989Study directorPhase 4Jan 1, 2022
- NCT05448989Lead sponsorPhase 4Jan 1, 2022
- NCT05357326Lead sponsorPhase 4Jul 1, 2021
- NCT04699357Lead sponsorN/AFeb 1, 2021
Details
- Last known activity
- Jun 1, 2025